Health Claims and FTC Advertising Law

Size: px
Start display at page:

Download "Health Claims and FTC Advertising Law"

Transcription

1 Health Claims and FTC Advertising Law Institute of Medicine Food Forum Workshop The Human Microbiome, Diet, and Health Michelle Rusk, Attorney* Division of Advertising Practices *Staff presentation does not necessarily represent views of FTC or any Commissioner. February 23, 2012

2 Overview Coordination with FDA FTC advertising law basics What constitutes adequate substantiation for health claims Recent case examples

3 FTC/FDA Coordination FTC authority overlaps with FDA for foods, supplements, drugs, other health and medical products Two agencies coordinate closely Liaison Agreement FDA Primary authority over labeling FTC Primaryauthority authority over advertising (except Rx drugs)

4 FTC/FDA Coordination FTC legal framework differs from FDA: Primarily a law enforcement agency No pre market approval of claims No regulatory distinction between product categories (drug, supplement, food) No regulatory distinction between types of claims li (health, disease, structure/function) t ti

5 FTC Advertising Law FTC Act, Sections 5 and 12 Advertising must be truthful and not misleading. Objective claims must be substantiated before they are made. All advertising investigations begin with two basic questions

6 1. What claims are conveyed?

7 2. Are the claims substantiated?

8 FTC Substantiation Policy General Doctrine: TheFTC typically requires claims about the efficacy or safety of dietary supplements to be supported with competent and reliable scientific evidence, defined as tests, analyses, research, studies or other evidence based on the expertise of professionals in the relevant area, conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results. (Sec II.B)

9 FTC Substantiation Policy In other words: Rigorous but flexible approach (look to experts in the field) No fixed formula for number, length, size of studies (quality over quantity) Generally expect double blind placebo controlled controlled human clinicals FDA substantiation guidance for supplements closely mirrors FTC substantiation policy

10 FTC Substantiation Policy Internal Validity of Studies Control and blinding Duration (does effect persist?) Dose/response relationship Recognized biological mechanism Peer review/publication in reputable journal is a plus Statistically significant AND clinically meaningful

11 FTC Substantiation Policy Context Don t evaluate studies in isolation Consider all relevant evidence Reconcile inconsistent/conflicting results Claim i may need to be qualified Don t make claim if weight of evidence contradicts t

12 FTC Substantiation Policy

13 FTC Substantiation Policy Relevance to Product/Claim: Product and claims should match the science Amount/form of ingredient Population studied Degree/nature of effect Strength of the science

14 Recent Actions The Dannon Company, Inc. (Consent 2009)

15 Recent Actions Danactive children s dairy drink helps prevent colds and flu ( L. CaseiImmunitatas ) t Activia yogurt relieves irregularity ( Bifidus Regularis ) Results in test group were not statistically significant ifi compared to placebo group; 8 out of 10 studies on Activia showed no significant effect The Dannon Company, Inc. (Consent 2009)

16 Recent Actions Nestlé Healthcare Nutrition (consent 2010)

17 Recent Actions Probiotic straw and drink for children Claims: prevention of upper respiratory tract infections; protects against cold and flu; reduces absence from school; reduces duration of acute diarrhea in children up to 13 Some good evidence but claims went beyond science Nestlé Healthcare Nutrition (Consent 2010)

18 Final Thoughts New FTC order language more concrete and specific about the science required to substantiate claims Not more burdensome; just more transparent Order may require prior FDA approval under a drug monograph or pursuant to NLEA for disease prevention/risk reduction Order may specify two studies, on the product or essentially equivalent product, conducted by different and independent researchers New language applies ONLY to the claims and products covered by the order.

19 More guidance at business.ftc.gov

The opinions expressed are the speaker s and not his company s.

The opinions expressed are the speaker s and not his company s. May 13, 2010 James Brooks, Ph.D. Vice President, Science & Technology Christine Burdick-Bell, J.D. Vice President, Legal & Regulatory Affairs Pharmavite LLC The opinions expressed are the speaker s and

More information

FDA Regulation of Claims on Dietary Supplement and Food Products

FDA Regulation of Claims on Dietary Supplement and Food Products FDA Regulation of Claims on Dietary Supplement and Food Products Patricia Kaeding August 2004 Topics FDA Overview What are claims Why claims matter Categories of claims Regulatory requirements for types

More information

Translating the science into efficacy claims on probiotic or prebiotic products in the US market

Translating the science into efficacy claims on probiotic or prebiotic products in the US market Translating the science into efficacy claims on probiotic or prebiotic products in the US market American Dairy Science Association Annual Meeting July 13, 2010 Dairy & Food Culture Technologies Consulting

More information

Is POM Wonderful Really Wonderful? How the FTC, the FDA and Private Litigation Address Deceptive Food Advertising

Is POM Wonderful Really Wonderful? How the FTC, the FDA and Private Litigation Address Deceptive Food Advertising Is POM Wonderful Really Wonderful? How the FTC, the FDA and Private Litigation Address Deceptive Food Advertising Dee Pridgen October 9, 2014 14 th Consumer Issues Conference Pom Wonderful achieve immortality?

More information

Advertising: The Federal Trade Commission and Private Rights of Action Venable LLP

Advertising: The Federal Trade Commission and Private Rights of Action Venable LLP Advertising: The Federal Trade Commission and Private Rights of Action 2012 Venable LLP 1 Agenda FTC s Role and Authority Claim Substantiation Private Rights of Action 2 FTC s Role and Authority FTC Authority

More information

Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs

Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs This document is scheduled to be published in the Federal Register on 12/13/2016 and available online at https://federalregister.gov/d/2016-29770, and on FDsys.gov [BILLING CODE: 6750-01S] FEDERAL TRADE

More information

What Regulators and Other Attorneys Will Not Tell You About FDA, FTC, and Class Action Lawsuits Venable LLP

What Regulators and Other Attorneys Will Not Tell You About FDA, FTC, and Class Action Lawsuits Venable LLP What Regulators and Other Attorneys Will Not Tell You About FDA, FTC, and Class Action Lawsuits 2012 Venable LLP 1 Agenda Current Enforcement Trends What is a Claim? Substantiation Hot Topic Claims FDA

More information

Give Me a Break, Is That Really a Disease Claim?

Give Me a Break, Is That Really a Disease Claim? Give Me a Break, Is That Really a Disease Claim? Najla Guthrie, President/CEO KGK Synergize Todd A. Harrison Partner Venable LLP Claudia A. Lewis, Partner Venable LLP ENGREDEA 2014 March 7, 2014 2012 Venable

More information

Substantiation of Health Claims in Advertising. Richard L. Cleland Division of Advertising Practices Federal Trade Commission

Substantiation of Health Claims in Advertising. Richard L. Cleland Division of Advertising Practices Federal Trade Commission Substantiation of Health Claims in Advertising Richard L. Cleland Division of Advertising Practices Federal Trade Commission The FTC Act prohibits: Background unfair or deceptive acts or practices in or

More information

The science and regulations of probiotic food and supplement product labeling

The science and regulations of probiotic food and supplement product labeling Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Probiotic Foods and Supplements The science and regulations of probiotic food and supplement product labeling Mary

More information

December 4, 2017 VIA ELECTRONIC SUBMISSION

December 4, 2017 VIA ELECTRONIC SUBMISSION VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement

More information

Claims That Can Get You in Trouble

Claims That Can Get You in Trouble Claims That Can Get You in Trouble What s New in Advertising Claims for Dietary Supplements Steve Mister President & CEO, CRN FTC Requirements for Advertising Claims must be truthful, not misleading and

More information

NEUROSCIENCE TRIALS OF THE FUTURE: A WORKSHOP Pragmatic Trials: Challenges and Opportunities for Neuroscience Trials

NEUROSCIENCE TRIALS OF THE FUTURE: A WORKSHOP Pragmatic Trials: Challenges and Opportunities for Neuroscience Trials NEUROSCIENCE TRIALS OF THE FUTURE: A WORKSHOP Pragmatic Trials: Challenges and Opportunities for Neuroscience Trials Mark J. Cziraky, PharmD, CLS Vice President of Research HealthCore Inc. Wilmington,

More information

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP Getting Your Ingredient to Market: Understanding Your Regulatory Options 2013 Venable LLP 1 Overview of the Governing Laws 1. The Federal Food, Drug, and Cosmetic Act ("FD&C Act"): Requires foods, cosmetics,

More information

2:00pm - 3:00pm: Breakout 3 - Case Discussions Technician Option: Functional Foods

2:00pm - 3:00pm: Breakout 3 - Case Discussions Technician Option: Functional Foods 2:00pm - 3:00pm: Breakout 3 - Case Discussions Technician Option: Functional Foods ACPE UAN 107-000-11-017-L01-T Activity Type: Knowledge-Based 0.1 CEU/1.0 Hr Program Objectives for Technicians: Upon completion

More information

II. History and importance of defining Healthy : Government/regulatory science perspective

II. History and importance of defining Healthy : Government/regulatory science perspective II. History and importance of defining Healthy : Government/regulatory science perspective Barbara Schneeman, Ph.D. Professor Emerita of Nutrition University of California, Davis Main Question What are

More information

GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS

GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS 1 CAC/GL 23-1997 GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS CAC/GL 23-1997 Nutrition claims should be consistent with national nutrition policy and support that policy. Only nutrition claims that

More information

Gyan Rai, PhD 06/04/2015

Gyan Rai, PhD 06/04/2015 * Gyan Rai, PhD 06/04/2015 Objectives: 2 1. Current Definition of Probiotics 2. Regulatory Categorization & Intended Uses 3. Probiotics & Medical Foods- How to Fit? 4. Regulatory Implications & Considerations

More information

US Whole Grain Regulatory & Policy Framework

US Whole Grain Regulatory & Policy Framework US Whole Grain Regulatory & Policy Framework International Forum for Whole Grain Foods Development Hosted by: PNDC, Whole Grains Council & Grains for Health Foundation Kathy Wiemer MS, RD Fellow/Director

More information

Understanding probiotics and health

Understanding probiotics and health Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,

More information

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

Phase 2b/3 Topline Trial Results

Phase 2b/3 Topline Trial Results Phase 2b/3 Topline Trial Results RP-G28 For the Treatment of Lactose Intolerance March 2017 Forward - Looking Statement To the extent that statements contained in this presentation are not descriptions

More information

U.S. FDA Perspective on Food Supplements/TM

U.S. FDA Perspective on Food Supplements/TM U.S. FDA Perspective on Food Supplements/TM IKHLAS A. KHAN National Center for Natural Products Research, Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy,

More information

Food Labeling Enforcement and Compliance Priorities in the Current Environment

Food Labeling Enforcement and Compliance Priorities in the Current Environment Food Labeling Enforcement and Compliance Priorities in the Current Environment Veronica Colas, Senior Associate April 12, 2018 Role of FDA Regulations and Guidance in Class Action Litigation Why Class

More information

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) January 12, 2011 Cristi Stark, MS Senior Regulatory Health Project Manager Office

More information

Overview Consumer Health Products Law and Compliance Issues

Overview Consumer Health Products Law and Compliance Issues Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services Consumer

More information

Problems with the 1906 Act

Problems with the 1906 Act Problems with the 1906 Act failed to provide clear-cut meanings and specific means for enforcement insufficient funding for enforcement USDA was responsible for testing, but no standards for foods were

More information

Paul M. Coates, Ph.D.

Paul M. Coates, Ph.D. Dietary Supplements in the United States: Claims and Evidence The National Institute of Health and Nutrition December 2008 Paul M. Coates, Ph.D. Office of Dietary Supplements National Institutes of Health

More information

FDA s Evidence-Based Review System

FDA s Evidence-Based Review System Food & Drug January 28, 2009 FDA Releases Final Guidance for Evidence-Based Review System for the Scientific Evaluation of Health Claims On January 16, 2009, the Food and Drug Administration (FDA) announced

More information

A NATURAL EXPERIMENT: CLAIMS, Consumers, and CASES. Neal Hooker, Christopher Simons, Efthimios Parasidis. Efthimios Parasidis

A NATURAL EXPERIMENT: CLAIMS, Consumers, and CASES. Neal Hooker, Christopher Simons, Efthimios Parasidis. Efthimios Parasidis A NATURAL EXPERIMENT: CLAIMS, Consumers, and CASES Neal Hooker, Christopher Simons, Efthimios Parasidis The Ohio State University Efthimios Parasidis Associate Professor of Law and Public Health The Ohio

More information

Understanding Today s Probiotics Regulations in South East Asia. Wai Mun Poon Regulatory Affairs Consultant

Understanding Today s Probiotics Regulations in South East Asia. Wai Mun Poon Regulatory Affairs Consultant Understanding Today s Probiotics Regulations in South East Asia Wai Mun Poon Regulatory Affairs Consultant waimun@wongsjasia.com Probiotic Foods in South East Asia More probiotic foods are being introduced

More information

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Food Labeling: Policy Rationale IFT Food Policy Impact, 2011 Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements CFSAN-FDA General Labeling Provisions FDA s authority to regulate

More information

Homeopathy: the need for robust evidence to inform consumer choice

Homeopathy: the need for robust evidence to inform consumer choice Homeopathy: the need for robust evidence to inform consumer choice Opening and Introduction: Dame Anne Glover and Thierry Courvoisier Homeopathy and the EU: Robin Fears Homeopathy in Sweden: Dan Larhammar

More information

FDLI ANNUAL CONFERENCE May 4, 2018

FDLI ANNUAL CONFERENCE May 4, 2018 FDLI ANNUAL CONFERENCE May 4, 2018 DIETARY SUPPLEMENTS RETAILER ISSUES AND LIABILITY Jean Frydman, Partner, Chair FDA Practice Fox Rothschild, LLP FDA Concern is Safety Only DHSEA Act of 1994 Know what

More information

G O L D E N S E A L R O O T P O W D E R

G O L D E N S E A L R O O T P O W D E R T H E A M E R I C A N H E R B A L P R O D U C T S A S S O C I A T I O N S GUIDANCE CA PROPOSITION 65: G O L D E N S E A L R O O T P O W D E R AUGUST 2016 This document is the property of the American Herbal

More information

Nutrition Labeling Laws for Food and Supplements Timeline

Nutrition Labeling Laws for Food and Supplements Timeline Federal Food, Drug, and Cosmetic Act (FDCA) Pure Food and Drug Act (PFDA) Wheeler-Lea Act st Multivitamin 920 938 Food Additives Amendment 906 st Dietary 934 958 Supplements Year Description Reference

More information

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG

More information

Particular challenges of evaluation of herbal combination products

Particular challenges of evaluation of herbal combination products Particular challenges of evaluation of herbal combination products Reinhard Länger, PhD, Assoc. Prof. Austrian Medicines and Medical Devices Agency (AGES MEA/BASG) Dept. for Herbal, Homeopathic & Veterinary

More information

Silliker Nutrient and Health Claims U.S. and Canadian Regulatory Guide

Silliker Nutrient and Health Claims U.S. and Canadian Regulatory Guide Silliker Nutrient and U.S. and Canadian Regulatory Guide Technical Content by Food Consulting Company 2013 Edition With over 40 years of experience and part of the Mérieux Alliance group of companies,

More information

Scientific Exchange: What Every Compliance Officer Should Consider

Scientific Exchange: What Every Compliance Officer Should Consider Scientific Exchange: What Every Compliance Officer Should Consider Saul B. Helman, M.D October 21, 2015 The Sixteenth Pharmaceutical Compliance Congress and Best Practices Forum DISPUTES & INVESTIGATIONS

More information

Public Hearing Before U.S. Food and Drug Administration

Public Hearing Before U.S. Food and Drug Administration Substances in Food and Labeling; Regulatory Framework for Foods that Companies are Marketing as Functional Foods Public Hearing Before U.S. Food and Drug Administration Ilene Ringel Heller Senior Staff

More information

Mark M. Yacura. Partner

Mark M. Yacura. Partner Mark M. Yacura Partner Mark M. Yacura focuses his practice primarily on FDA legal and regulatory matters. He has practiced in this area for more than 30 years. He represents his clients before administrative

More information

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Report of the Council on Ethics, Bylaws and Judicial Affairs on Advisory Opinion 5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Ethical Advertising under ADA Code:

More information

The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016

The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016 INFORMATION NOTE INTENDED FOR KNOWLEDGE HUB The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016 This note is to alert you to the fact that the English Statutory

More information

TGA: the current regulatory reform agenda

TGA: the current regulatory reform agenda TGA: the current regulatory reform agenda ASMI 2012 Conference: 13 November 2012 Future proofing the consumer healthcare industry Dr John Skerritt, National Manager The Therapeutic Goods Administration

More information

Improvising Claims. - Dr. R. B. Smarta

Improvising Claims. - Dr. R. B. Smarta Improvising Claims - Dr. R. B. Smarta Labelling is usually perceived as an important aspect in informing the consumers about the contents of food/nutraceuticals in the finished products. Claims allow the

More information

Nutritional Criteria for Labeling Claims

Nutritional Criteria for Labeling Claims Nutritional Criteria for Labeling Claims Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements Center for Food Safety and Applied Nutrition/ Food and Drug Administration Department

More information

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center

More information

Web Meeting Sep 20, Presented by: Kimberly Belsky, DIA AdPromo WG Chair DIA, Inc. All Rights Reserved.

Web Meeting Sep 20, Presented by: Kimberly Belsky, DIA AdPromo WG Chair DIA, Inc. All Rights Reserved. OPDP Warning Letter Posted Sep 2017 FDA Draft Guidance Medical Product Communications That Are Consistent With the FDA-Required Labeling Q&A s (Issued January 2017) Web Meeting Sep 20, 2017 Presented by:

More information

Overview of IOM Studies Relevant to Food and Beverage Marketing to U.S. Children and Youth

Overview of IOM Studies Relevant to Food and Beverage Marketing to U.S. Children and Youth Overview of IOM Studies Relevant to Food and Beverage Marketing to U.S. Children and Youth DHHS & FTC Workshop Marketing, Self-Regulation, and Childhood Obesity July 15, 2005 Vivica Kraak, M.S., R.D. Institute

More information

Food and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law

Food and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law Food and Drug Law Fall 2009 Syllabus Professor Jesson Hamline University School of Law General course Information: Course: Food and Drug Law Credits: 2 Classroom: Law 103 Time: Thursdays, 4-5:50 p.m. Professor:

More information

Access to clinical trial information and the stockpiling of Tamiflu. Department of Health

Access to clinical trial information and the stockpiling of Tamiflu. Department of Health MEMORANDUM FOR THE COMMITTEE OF PUBLIC ACCOUNTS HC 125 SESSION 2013-14 21 MAY 2013 Department of Health Access to clinical trial information and the stockpiling of Tamiflu 4 Summary Access to clinical

More information

Aligning a Product s Marketing, Regulatory and IP Plans

Aligning a Product s Marketing, Regulatory and IP Plans Aligning a Product s Marketing, Regulatory and IP Plans CLIENT ALERT September 8, 2017 Raymond A. Miller millerra@pepperlaw.com Barry H. Boise boiseb@pepperlaw.com Jessica A. Rickabaugh rickabaughj@pepperlaw.com

More information

PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)

PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND) PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT Karen Jensen, (Retired ND) Today many people are aware of the benefits of maintaining a healthy gut. As a result, probiotic use is becoming ever more popular.

More information

Study Endpoint Considerations: Final PRO Guidance and Beyond

Study Endpoint Considerations: Final PRO Guidance and Beyond Study Endpoint Considerations: Final PRO Guidance and Beyond Laurie Burke Associate Director for Study Endpoints and Labeling OND/CDER/FDA Presented at: FIRST ANNUAL PATIENT REPORTED OUTCOMES (PRO) CONSORTIUM

More information

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No. VIA ELECTRONIC SUBMISSION July 3, 2018 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: National Bioengineered Food Disclosure Standard;

More information

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Andrea Leonard-Segal, M.D., M.S. Director, Division of Nonprescription Clinical Evaluation 1 Contents

More information

Effect of the First Amendment on Off-Label Marketing

Effect of the First Amendment on Off-Label Marketing www.bipc.com Effect of the First Amendment on Off-Label Marketing Linda Pissott Reig Shareholder 550 Broad Street, Suite 810, Newark, NJ 07102-4582 973 424 5618 linda.reig@bipc.com ABA Section of Litigation

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President

More information

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov

More information

UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION. William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill COMPLAINT

UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION. William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill COMPLAINT 0923087 UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION COMMISSIONERS: Jon Leibowitz, Chairman William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill ) In the Matter of ) ) DOCKET NO. NESTLÉ HEALTHCARE

More information

Regulation of Dietary Supplements

Regulation of Dietary Supplements (name redacted) Analyst in Health Policy December 16, 2014 Congressional Research Service 7-... www.crs.gov R43062 Summary Many Americans take dietary supplements (e.g., vitamins, herbs, sports nutrition

More information

Consistent with Labeling Final Guidance: Implications for Devices

Consistent with Labeling Final Guidance: Implications for Devices Consistent with Labeling Final Guidance: Implications for Devices Vernessa Pollard, Partner, McDermott Will & Emery Cassie Scherer, Principal Legal Counsel, Medtronic Jeffrey Shapiro, Director, Hyman,

More information

Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND)

Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) 02/02/16 description Does a study that claims their dietary supplement promotes healthy joints and cartilage or

More information

CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS

CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS I INTRODUCTION This document provides guidance for interpreting and implementing the Council Directive

More information

Advertising by Orthopaedic Surgeons

Advertising by Orthopaedic Surgeons Opinion on Ethics and Professionalism Advertising by Orthopaedic Surgeons An AAOS Opinion on Ethics and Professionalism is an official AAOS statement dealing with an ethical issue, which offers aspirational

More information

GAO FOOD SAFETY. Improvements Needed in Overseeing the Safety of Dietary Supplements and Functional Foods. Report to Congressional Committees

GAO FOOD SAFETY. Improvements Needed in Overseeing the Safety of Dietary Supplements and Functional Foods. Report to Congressional Committees GAO United States General Accounting Office Report to Congressional Committees July 2000 FOOD SAFETY Improvements Needed in Overseeing the Safety of Dietary Supplements and Functional Foods GAO/RCED-00-156

More information

market safety evaluations required of other new food ingredients.

market safety evaluations required of other new food ingredients. Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Students will: Objectives: Understand supplement definitions Be

More information

Comments in Response to the April 18 Workshop: Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care

Comments in Response to the April 18 Workshop: Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care Federal Trade Commission Office of the Secretary 600 Pennsylvania Avenue Washington, DC 20580 RE: Comments in Response to the April 18 Workshop: Now Hear This: Competition, Innovation, and Consumer Protection

More information

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018 An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,

More information

Are You Considering Using CAM?

Are You Considering Using CAM? Are You Considering Using CAM? Decisions about your health care are important including decisions about whether to use complementary and alternative medicine (CAM). The National Center for Complementary

More information

PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY

PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY OBJECTIVES What is the difference between herbal supplements, over the counter medicines, and prescription medicines?

More information

Common Criteria for Cosmetic Claims

Common Criteria for Cosmetic Claims Common Criteria for Cosmetic Claims Job done or the opening of Pandora s Box? Dr Chris Flower Director-General Cosmetic, Toiletry and Perfumery Association www.ctpa.org.uk Presentation summary: CAP/BCAP

More information

OUR COMMITMENT OPEN DIALOGUE & DEBATE COMMITMENT TO EDUCATION

OUR COMMITMENT OPEN DIALOGUE & DEBATE COMMITMENT TO EDUCATION Everyday we make choices and take actions that ensure the scientific-basis and quality of Nature Made vitamins and supplements. As a vitamin and supplement company, for Nature Made transparency means:

More information

STATEMENT OF THE AMERICAN DENTAL ASSOCIATION ON REGULATION BY STATE BOARDS OF DENTISTRY OF MISLEADING DENTAL SPECIALTY CLAIMS.

STATEMENT OF THE AMERICAN DENTAL ASSOCIATION ON REGULATION BY STATE BOARDS OF DENTISTRY OF MISLEADING DENTAL SPECIALTY CLAIMS. STATEMENT OF THE AMERICAN DENTAL ASSOCIATION ON REGULATION BY STATE BOARDS OF DENTISTRY OF MISLEADING DENTAL SPECIALTY CLAIMS August 10, 2018 From time to time, general dentists who are not adequately

More information

Probiotics. Wide spectrum of important health benefits

Probiotics. Wide spectrum of important health benefits Probiotics Part 1: What Are Probiotics? Probiotics are live microorganisms that inhabit the respiratory and gastrointestinal tracts and the skin. They are often referred to as friendly bacteria as they

More information

Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective

Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective Modified Risk Tobacco Product Applications A Succinct ENDS Industry Perspective Patricia I. Kovacevic General Counsel, Chief Compliance Officer Presentation to the Food and Drug Law Institute Tobacco Conference,

More information

Nestle Infant Nutrition 10/31/14

Nestle Infant Nutrition 10/31/14 U.S. Food and Drug Administration Protecting and Promoting Your Health Nestle Infant Nutrition 10/31/14 OCT 31, 2014 Department of Health and Human Services Public Health Service Food and Drug Administration

More information

Regulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division

Regulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division Regulatory Systems of Health Claims in Japan June, 2011 Consumer Affairs Agency Food Labelling Division Mission of the Consumer Affairs Agency (CAA) Article 2 of the Consumer Basic Act sets out the state

More information

GSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements

GSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements GSCI 2202 FOOD FOR HEALTH Eat to compete: Dietary Supplements Dietary supplements on the market are: NOT regulated Could contain illegal substances Could be costly Could be harmful Current laws on dietary

More information

An update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading

An update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading Sugar, salt and fat: strategies to reduce consumption Nutritional labelling: standards, guides and regulations An update on the regulatory framework for labelling across the EU Dr David Jukes Department

More information

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives)

(Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives) ก ก 2553 ก : ก (Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color Additives) : ก ก ก : ก ก ก : 2552 : 2552 1 ก 5 ก : ก (Cochineal

More information

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate

More information

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy

More information

Challenges and solutions in making evidence-based national vaccination policies and recommendations

Challenges and solutions in making evidence-based national vaccination policies and recommendations Challenges and solutions in making evidence-based national vaccination policies and recommendations Philippe Duclos, WHO 15th ADVAC, Les Pensières, Veyrier du Lac, May 19, 2014 Developing evidence-based

More information

CIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS

CIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS CIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS SANCO/1341/2001 MIN/144/01E Final CIAA 2 CIAA KEY PRINCIPLES ON CLAIMS The Food and Drink industry has responded to government

More information

Agency Information Collection Activities; Submission for Office of Management and Budget

Agency Information Collection Activities; Submission for Office of Management and Budget This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Presentation: Philip G. Hampton, II Haynes and Boone, LLP (202) September 14, 2017

Presentation: Philip G. Hampton, II Haynes and Boone, LLP (202) September 14, 2017 Presentation: Philip G. Hampton, II Haynes and Boone, LLP (202) 654-4533 September 14, 2017 What is a Trademark? A trademark is any word, product name, symbol or device that identifies the goods or services

More information

Documents Regarding Drug Abuse Assessments

Documents Regarding Drug Abuse Assessments Overview of the FDA Guidance Documents Regarding Drug Abuse Assessments ABUSE DETERRENT FORMULATION SCIENCE MEETING DISCUSSION OF THE FDA DRAFT GUIDANCE FOR INDUSTRY: ABUSE DETERRENT OPIOIDS EVALUATION

More information

GUIDELINES: PEER REVIEW TRAINING BOD G [Amended BOD ; BOD ; BOD ; Initial BOD ] [Guideline]

GUIDELINES: PEER REVIEW TRAINING BOD G [Amended BOD ; BOD ; BOD ; Initial BOD ] [Guideline] GUIDELINES: PEER REVIEW TRAINING BOD G03-05-15-40 [Amended BOD 03-04-17-41; BOD 03-01-14-50; BOD 03-99-15-48; Initial BOD 06-97-03-06] [Guideline] I. Purpose Guidelines: Peer Review Training provide direction

More information

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years Gary L. Yingling Food Policy Impact December 2011 Copyright 2011 by K&L Gates LLP. All rights reserved. Brief Historical

More information

The science behind labeling issues and health claims a European perspective

The science behind labeling issues and health claims a European perspective 2005 CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Bioactive Food Components The science behind labeling issues and health claims a European perspective Dr Michele Kellerhals Scientific and

More information

FDA issues long-awaited final guidance on when a device modification requires a new 510(k)

FDA issues long-awaited final guidance on when a device modification requires a new 510(k) FDA issues long-awaited final guidance on when a device modification requires a new 510(k) November 2, 2017 Six years after its first attempt to update its 20-year-old guidelines for when modifications

More information

Protein Quality and Labeling: Defending Attacks from Regulators, Attorneys and Competitors

Protein Quality and Labeling: Defending Attacks from Regulators, Attorneys and Competitors Protein Quality and Labeling: Defending Attacks from Regulators, Attorneys and Competitors May 23, 2018 Justin J. Prochnow prochnowjj@gtlaw.com (303) 572-6562 GREENBERG TRAURIG, LLP ATTORNEYS AT LAW WWW.GTLAW.COM

More information

Update from the European Commission s Working Group meeting on health claims, 31 March 2015

Update from the European Commission s Working Group meeting on health claims, 31 March 2015 Update from the European Commission s Working Group meeting on health claims, 31 March 2015 There was discussion on a generic descriptor application and a number of health claims, including those mentioned

More information

New York Attorney General Targets Supplements at Major Retailers

New York Attorney General Targets Supplements at Major Retailers New York Attorney General Targets Supplements at Major Retailers By ANAHAD O'CONNOR NY Times FEBRUARY 3, 2015 12:00 AM A Target in East Harlem. It and three other retailers GNC, Walgreens and Walmart were

More information

REGULATIONS IN FOOD INGREDIENTS

REGULATIONS IN FOOD INGREDIENTS REGULATIONS IN FOOD INGREDIENTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com Catherine

More information

dietary supplements are not subject to the premarket safety evaluations required of other new food ingredients.

dietary supplements are not subject to the premarket safety evaluations required of other new food ingredients. Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Objectives: Students will: Understand supplement definitions Be

More information

ELEVEN REASONS WHY S IS BAD PUBLIC POLICY. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million.

ELEVEN REASONS WHY S IS BAD PUBLIC POLICY. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million. ELEVEN REASONS WHY S. 2461 IS BAD PUBLIC POLICY 1. Creates New Bureaucracy. Clinton Admin. FY00 budget request for FDA tobacco regulation was $34 million. S.2461 includes a tax increase of $300 million

More information

Content. Research Rationale. Perceptions, Attitudes and Understanding of Health Claims on Milk for Children among the Indonesian Mothers

Content. Research Rationale. Perceptions, Attitudes and Understanding of Health Claims on Milk for Children among the Indonesian Mothers Perceptions, Attitudes and Understanding of Health Claims on Milk for Children among the Indonesian Mothers Ms Karin Tan PhD Candidate Newcastle University (Singapore) Why Who & How Results Next Steps

More information